Eric van der Putten

Eric van der Putten is an accomplished professional in the oncology field, currently serving as a Non-Executive Director at MIMETAS and as a Director at Modra Pharmaceuticals. Since May 2016, Eric has contributed to Modra Pharmaceuticals' mission of improving cancer therapy through innovative oral bioavailability solutions. Additionally, as a Partner at Aglaia Oncology Funds, Eric focuses on investing in pioneering cancer therapies. Earlier experience includes co-founding SMS-oncology, leading clinical trials, and serving in executive roles at various organizations, including INC Research Netherlands and NDDO Oncology. Eric holds multiple degrees in Biochemistry, Immunology, Pathology, and Histology from recognized institutions and has completed relevant executive education courses.